Articles dans des revues avec comité de lecture (129)
  1. 47. Urizar Andrieu, E., Claeysen, S., Deupí, X., Govaerts, C., Costagliola, S., Vassart, G., & Pardo, L. (2005). An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. The Journal of biological chemistry, 280(17), 17135-17141. doi:10.1074/jbc.M414678200
  2. 48. Delbaere, A., Smits, G., De Leener, A., Costagliola, S., & Vassart, G. (2005). Understanding ovarian hyperstimulation syndrome. Endocrine, 26(3), 285-290. doi:10.1385/ENDO:26:3:285
  3. 49. Migeotte, I., Riboldi, E., Franssen, J.-D., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., Sozzani, S., Parmentier, M., & Communi, D. (2005). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. The Journal of Experimental Medicine, 201(1), 83-93. doi:10.1084/jem.20041277
  4. 50. Daelemans, C., Smits, G., De Maertelaer, V., Costagliola, S., Englert, Y., Vassart, G., & Delbaere, A. (2004). Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. The Journal of clinical endocrinology and metabolism, 89(12), 6310-6315. doi:10.1210/jc.2004-1044
  5. 51. Costagliola, S., Bonomi, M., Morgenthaler, N. G., Van Durme, J., Panneels, V., Refetoff, S., & Vassart, G. (2004). Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Molecular endocrinology, 18(12), 3020-3034. doi:10.1210/me.2004-0231
  6. 52. Salek, M., Costagliola, S., & Lehmann, W. D. (2004). Protein tyrosine-O-sulfation analysis by exhaustive product ion scanning with minimum collision offset in a NanoESI Q-TOF tandem mass spectrometer. Analytical chemistry, 76(17), 5136-5142. doi:10.1021/ac0400414
  7. 53. Montanelli, L., Van Durme, J., Smits, G., Bonomi, M., Rodien, P., Devor, E. J., Moffat-Wilson, K., Pardo, L., Vassart, G., & Costagliola, S. (2004). Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Molecular endocrinology, 18(8), 2061-2073. doi:10.1210/me.2004-0036
  8. 54. Montanelli, L., Delbaere, A., Di Carlo, C., Nappi, C., Smits, G., Vassart, G., & Costagliola, S. (2004). A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. The Journal of clinical endocrinology and metabolism, 89(4), 1255-1258. doi:10.1210/jc.2003-031910
  9. 55. Delbaere, A., Smits, G., Olatunbosun, O., Pierson, R., Vassart, G., & Costagliola, S. (2004). New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Human reproduction, 19(3), 486-489. doi:10.1093/humrep/deh124
  10. 56. Vassart, G., Pardo, L., & Costagliola, S. (2004). A molecular dissection of the glycoprotein hormone receptors. Trends in biochemical sciences, 29(3), 119-126. doi:10.1016/j.tibs.2004.01.006
  11. 57. Costa, M. J., Song, Y., Macours, P., Massart, C., Many, M.-C., Costagliola, S., Dumont, J. E., Van Sande, J., & Vanvooren, V. (2004). Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology, 145(3), 1464-1472. doi:10.1210/en.2003-1432
  12. 58. Vassart, G., & Costagliola, S. (2004). A physiological role for the posttranslational cleavage of the thyrotropin receptor? Endocrinology, 145(1), 1-3. doi:10.1210/en.2003-1225
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>